** Drug developer's shares KOOL.O rise as much as 35.33%
to $4.75, hitting over a year high, after co says it entered
into a supply agreement for its X-Series products
** Stock set for best day in about ten months, if gains hold
** KOOL's subsidiary signs agreement with a life science
distributor to market X-Series cell-processing products globally
urn:newsml:reuters.com:*:nPn9s0cg3a
** Under the agreement, KOOl to receive a $2 mln
distribution fee and future market support for granting
exclusive rights
** Stock among highest percentage gainers across all U.S.
exchanges
** Including session's gains, stock up ~68%
(Reporting by Abhishek Manikandan in Bengaluru)
((Abhishek.Manikandan@thomsonreuters.com))